within Pharmacolibrary.Drugs.ATC.N;

model N05CH01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.15,
    Cl             = 41.7 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 2 / 1000000,
    adminCount     = 1,
    Vd             = 0.035,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.006883333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Melatonin is an endogenous hormone produced by the pineal gland involved in the regulation of circadian rhythms and sleep-wake cycles. As a drug, melatonin is primarily used to treat insomnia, jet lag, and circadian rhythm sleep disorders, and is available as an over-the-counter supplement in many countries. It is generally considered safe with limited adverse effects and is not approved as a prescription medication in most regions, but is widely used for sleep-related complaints.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters following oral administration of 2 mg controlled-release melatonin in healthy adult volunteers (both sexes, age range 18–65 years).</p><h4>References</h4><ol><li><p>Lalanne, S, et al., &amp; Tordjman, S (2021). Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder. <i>International journal of molecular sciences</i> 22(3) –. DOI:<a href=&quot;https://doi.org/10.3390/ijms22031490&quot;>10.3390/ijms22031490</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/33540815/&quot;>https://pubmed.ncbi.nlm.nih.gov/33540815</a></p></li><li><p>Harpsøe, NG, et al., &amp; Rosenberg, J (2015). Clinical pharmacokinetics of melatonin: a systematic review. <i>European journal of clinical pharmacology</i> 71(8) 901–909. DOI:<a href=&quot;https://doi.org/10.1007/s00228-015-1873-4&quot;>10.1007/s00228-015-1873-4</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/26008214/&quot;>https://pubmed.ncbi.nlm.nih.gov/26008214</a></p></li><li><p>Carloni, S, et al., &amp; Buonocore, G (2017). Melatonin Pharmacokinetics Following Oral Administration in Preterm Neonates. <i>Molecules (Basel, Switzerland)</i> 22(12) –. DOI:<a href=&quot;https://doi.org/10.3390/molecules22122115&quot;>10.3390/molecules22122115</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29194416/&quot;>https://pubmed.ncbi.nlm.nih.gov/29194416</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end N05CH01;
